IBM’s new Watson Genomics initiative will make it easier to fight cancer. It will now be possible to apply Watson’s data-crunching abilities to sequence the genome of a cancerous tumor and then access the most relevant information in medical literature to recommend a treatment option. The goal: personalized medicine for cancer patients based on their unique genomic profile. Experts say the most important factor will be the faster processing time of DNA insights made possible by Watson.
Join in on the conversation with Shreya Mathur when you subscribe to Exponentials.